Searle & Co. Timber Pharmaceuticals, Inc. Transaction History

Searle & Co.

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q1 2022 May 10, 2022	SELL	$0.28 - $0.41 $2,800 - $4,100	-10,000 Closed	0 $0
Q2 2021 Jul 29, 2021	BUY	$1.06 - $2.25 $10,600 - $22,500	10,000 New	10,000 $12,000

Ticker TMBR
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 146,524,992
Description
Timber Pharmaceuticals LLC, a clinical-stage biopharmaceutical company, engages in the development and commercialization of treatments for orphan dermatologic diseases. The company's lead product candidates include TMB-001, a patented topical formulation of isotretinoin that has completed Phase 2b clinical trial for the treatment of moderate to ...

Get notified when there are updates to the investment portfolio of Searle & Co., based on Form 13F filings with the SEC.

Stay updated on Searle & Co. with notifications on news.